A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and — Howard Feldman (UNIVERSITY O
PROJECT SUMMARY/ABSTRACT We are proposing a seamless phase 2A-B Proof of Concept (POC) trial of PQ 912, a first-in-class small molecule treatment for early Alzheimer’s disease (AD) with a unique mecha
| Project title | A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and |
|---|---|
| Project number | 5R01AG061146-02 |
| PI name | Howard Feldman |
| Institution | UNIVERSITY OF CALIFORNIA, SAN DIEGO |
| Funding mechanism | R01 |
| Agency | NIA |
| Award amount | $4.34M |
| Fiscal year | 2021 |
| Project start | 2019-04-01T00:00:00 |
| Project end | 2023-06-30T00:00:00 |
| Abstract | PROJECT SUMMARY/ABSTRACT We are proposing a seamless phase 2A-B Proof of Concept (POC) trial of PQ 912, a first-in-class small molecule treatment for early Alzheimer’s disease (AD) with a unique mecha |
| Key terms | <AD dementia><Address><Affect><Alzheimer><Alzheimer Disease test><Alzheimer Type Dementia><Alzheimer |
$799/mo
Try GrantRadar →